• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

May 7, 2010: Vaccines and Related Biological Products Advisory Committee Meeting Temporary Voting Members and Non Voting Temporary Voting Members

Center for Biologics Evaluation & Research
Vaccines & Related Biological Products Advisory Committee
Temporary Voting Members and Non Voting Temporary Voting Member
May 7, 2010

Andrew Cheung, Ph.D.  *
Research Microbiologist
Virus and Prion Research Unit
U.S. Department of Agriculture
Agricultural Research Service
1920 Dayton Avenue
Ames, IA  50010

John Coffin, Ph.D.  *
Professor of Molecular Biology & Microbiology
Department of Molecular Biology & Microbiology
Tufts University School of Medicine
136 Harrison Avenue
Boston, MA  02111

Bruce Gellin, M.D.  *
Director
National Vaccine Program Office (NVPO)
Health and Human Services
200 Independence Avenue, SW. Rm, 715H
Washington, DC  20201

Harry Greenberg, M.D.  *
Senior Associate Dean for Research
Joseph D. Grant Professor of Medicine and Microbiology & Immunology
Stanford University School of Medicine
291 Campus Drive, LKSC Bldg,
Rm LK3C02, MC 5216
Stanford, CA  94305

Stephen Hughes, Ph.D.  *
Director, HIV Drug Resistance Program
National Cancer Institute
NCI-Frederick
PO Box B, Building 539
Frederick, MD  21702

Philip LaRussa, M.D.  *
Professor of Clinical Pediatrics
Division of Pediatric Infectious Diseases
Department of Pediatrics
Columbia-Presbyterian Hospital
650 West 168th Street, P & S 3rd Fl, 435
New York, NY  10032

Pamela McInnes, D.D.S., Msc.  *
Director
Division of Extramural Research
National Institute of Dental and Craniofacial Research
National Institutes of Health
6701 Democracy Blvd, Rm 610, MS 4878
Bethesda, MD  20892

Theodore Tsai, M.D.  **
Senior Vice President, Scientific Affairs
Novartis Vaccines
350 Massachusetts Avenue
Cambridge, MA  02139

Melinda Wharton, M.D., M.P.H.  *
Deputy Director
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
Corporate Square Bldg 12, Rm 5107 (MS E05)
Atlanta, GA  30329

*        Temporary Voting Member
**      Non Voting Acting Industry Representative


Vaccines & Related Biological Products Advisory Committee
May 7, 2010
Speakers/Participants

Gordon Allan, Ph.D.
Professor
The Queens University Belfast
51 Cabin Hill Gardens
Belfast BTS 7AQ
Northern Ireland
United Kingdom

Norman Baylor, Ph.D.
Director, OVRR/CBER
Food and Drug Administration
Rockville, MD

Gary Dubin, M.D.
Vice President, Director
Global Clinical Development Center
GlaxoSmithKline

Leonard Friedland, M.D.
Vice President
North American Clinical and Medical Affairs
GlaxoSmithKline

Emmanuel Hanon, Ph.D.
Vice President
Global Vaccine Development
GlaxoSmithKline

Barbara Howe, M.D.
Vice President, Director
North American Vaccine Development
GlaxoSmithKline

Philip Krause, M.D.
Acting Associate Director for Medical
Policy & Vaccine Safety/OVRR/CBER
Food and Drug Administration
Rockville, MD

David Martin, M.D., M.P.H., FACOEM
Commander, U.S. Public Health Service
Acting Chief, OBE/VSB/TBSB/CBER
Food and Drug Administration
Rockville, MD

X.J. Meng, M.D., Ph.D.
Professor, Molecular Virology
Center for Molecular Medicine and Infectious Diseases
Virginia-Maryland College of Veterinary Medicine
Virginia Polytechnic Institute and State University
Blacksburg, VA

Umesh Parashar, M.D., M.P.H.
Lead, Viral Gastroenteritis Epidemiology Team
Centers for Disease Control and Prevention
Atlanta, GA

Keith Peden, Ph.D.
Senior Investigator, DVP, OVRR/CBER
Food and Drug Administration
Rockville, MD

Jerry Weir, Ph.D.
Director, DVP
OVRR/CBER
Food and Drug Administration
Rockville, MD